FDA drug approval

It was a chaotic year at the Food and Drug Administration. Thousands of staff left the agency. Leadership was unstable. Routine drug reviews were delayed, Commissioner Marty Makary reportedly attempted to intervene in an approval decision, and biologics chief Vinay Prasad overrode vaccine reviewers at least three times. It’s unclear how much that upheaval contributed […]